Skip to main content

Advertisement

SpringerLink
Log in

Empagliflozin, metformin and insulin degludec, during pregnancy: a case report

  • Case Report
  • Published:
Acta Diabetologica Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Marso SP, McGuire DK, Zinman B et al (2017) Efficacy and safety of degludec versus glargine in type 2 diabetes. N Engl J Med 377:723–732. https://doi.org/10.1056/NEJMoa1615692

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  2. Simmons D (2010) Metformin treatment for TYPE 2 diabetes in pregnancy? Best Pract Res Clin Endocrinol Metab 24:625–634. https://doi.org/10.1016/j.beem.2010.05.002

    Article  PubMed  CAS  Google Scholar 

  3. Zinman B, Marso SP, Poulter NR et al (2018) Day-to-day fasting glycaemic variability in DEVOTE: associations with severe hypoglycaemia and cardiovascular outcomes (DEVOTE 2). Diabetologia 61:48–57. https://doi.org/10.1007/s00125-017-4423-z

    Article  PubMed  Google Scholar 

  4. Highlights of prescribing information, Jardiance n.d. http://docs.boehringer-ingelheim.com/PrescribingInformation/PIs/Jardiance/jardiance.pdf

  5. Milluzzo A, Tumminia A, Scalisi NM, Frittitta L, Vigneri R, Sciacca L (2017) Insulin degludec in the first trimester of pregnancy: report of two cases. J Diabetes Investig. https://doi.org/10.1111/jdi.12721

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medicine and Aging Sciences, Aging and Translational Medicine Research Center (CeSI-Met), G. d’Annunzio University, Edificio CeSi, Room 271, Via Colle dell’Ara 1, 66100, Chieti, Italy

    G. Formoso, F. Ginestra, G. Di Dalmazi & A. Consoli

Authors
  1. G. Formoso
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. F. Ginestra
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. G. Di Dalmazi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. A. Consoli
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to G. Formoso.

Ethics declarations

Conflict of interest

A.C. has received speaker fees and/or consulting honoraria from Astra Zeneca, Boehringer Ingelheim, Eli Lilly, Merck Sharp & Dohme, Novartis, Novo Nordisk, Roche Diagnostics, Sanofi-Aventis, Takeda and has received research grant support from Eli Lilly and Novo Nordisk. G.F. has received speaker fees from Eli Lilly, Merck Sharp & Dohme, Menarini Diagnostics and Servier. F.G. and G.D.D. have received nothing.

Ethical approval

The study was in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments.

Informed consent

Informed consent was obtained from the patient included in the case report.

Additional information

Managed By Massimo Federici.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Formoso, G., Ginestra, F., Di Dalmazi, G. et al. Empagliflozin, metformin and insulin degludec, during pregnancy: a case report. Acta Diabetol 55, 759–761 (2018). https://doi.org/10.1007/s00592-018-1134-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00592-018-1134-y

Keywords

Search

Navigation